Recursion annual meeting elects Class III directors, approves say-on-pay

RECURSION PHARMACEUTICALS, INC.

Blake Borgeson, Ph.D. elected as Class III director with 165,914,956 votes for, 26,093,759 withheld.
Dean Y. Li, M.D., Ph.D. elected as Class III director with 166,211,058 votes for, 25,797,657 withheld.
Advisory resolution on executive compensation approved with 188,317,831 for, 2,887,180 against, 803,704 abstentions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.